|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
108,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
5,721,727 |
Avg
Vol: |
2,629,895 |
52
Week Range: |
$73.89 - $73.89 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-04-20 |
4 |
AS |
$46.43 |
$278,606 |
D/D |
(6,000) |
66,648 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-04-20 |
4 |
OE |
$12.74 |
$76,440 |
D/D |
6,000 |
72,648 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-04-20 |
4 |
AS |
$46.44 |
$262,456 |
D/D |
(5,651) |
57,646 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-04-20 |
4 |
OE |
$15.34 |
$86,686 |
D/D |
5,651 |
63,297 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-04-20 |
4 |
AS |
$46.44 |
$255,437 |
D/D |
(5,500) |
57,729 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-04-20 |
4 |
OE |
$15.34 |
$84,370 |
D/D |
5,500 |
63,229 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-04-06 |
4 |
AS |
$47.69 |
$286,159 |
D/D |
(6,000) |
66,648 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-04-06 |
4 |
OE |
$12.74 |
$76,440 |
D/D |
6,000 |
72,648 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-04-06 |
4 |
AS |
$47.61 |
$194,587 |
D/D |
(4,087) |
57,646 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-04-06 |
4 |
OE |
$15.40 |
$62,940 |
D/D |
4,087 |
61,733 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-04-06 |
4 |
AS |
$47.76 |
$156,686 |
D/D |
(3,281) |
57,729 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-04-06 |
4 |
OE |
$15.40 |
$50,527 |
D/D |
3,281 |
61,010 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-04-01 |
4 |
AS |
$47.98 |
$2,398,895 |
D/D |
(50,000) |
66,648 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-04-01 |
4 |
OE |
$42.69 |
$2,134,500 |
D/D |
50,000 |
116,648 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-03-31 |
4 |
AS |
$47.04 |
$996,161 |
D/D |
(21,179) |
57,729 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-03-31 |
4 |
OE |
$42.69 |
$904,132 |
D/D |
21,179 |
78,908 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-03-30 |
4 |
AS |
$47.10 |
$3,712,564 |
D/D |
(78,821) |
57,729 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-03-30 |
4 |
OE |
$42.69 |
$3,364,868 |
D/D |
78,821 |
136,550 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-03-23 |
4 |
AS |
$43.39 |
$320,546 |
D/D |
(7,387) |
57,646 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-03-23 |
4 |
OE |
$15.40 |
$113,760 |
D/D |
7,387 |
65,033 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2011-03-23 |
4 |
AS |
$43.52 |
$758,973 |
D/D |
(17,440) |
255,555 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-03-23 |
4 |
AS |
$43.39 |
$389,123 |
D/D |
(8,969) |
57,729 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-03-23 |
4 |
OE |
$15.40 |
$138,123 |
D/D |
8,969 |
66,698 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-03-23 |
4 |
AS |
$43.39 |
$260,344 |
D/D |
(6,000) |
66,648 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-03-23 |
4 |
OE |
$12.74 |
$76,440 |
D/D |
6,000 |
72,648 |
|
- |
|
772 Records found
|
|
Page 13 of 31 |
|
|